Virginia Retirement Systems’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $89.7K | Buy |
42,300
+8,700
| +26% | +$18.4K | ﹤0.01% | 924 |
|
|
2023
Q2 | $160K | Buy |
33,600
+15,600
| +87% | +$74.3K | ﹤0.01% | 936 |
|
|
2023
Q1 | $103K | Buy |
18,000
+5,600
| +45% | +$31.9K | ﹤0.01% | 1004 |
|
|
2022
Q4 | $125K | Buy |
+12,400
| New | +$125K | ﹤0.01% | 1087 |
|
|
2021
Q4 | – | Sell |
-5,500
| Closed | -$326K | – | 1121 |
|
|
2021
Q3 | $326K | Sell |
5,500
-800
| -13% | -$47.4K | ﹤0.01% | 866 |
|
|
2021
Q2 | $547K | Buy |
6,300
+3,400
| +117% | +$295K | 0.01% | 809 |
|
|
2021
Q1 | $239K | Buy |
+2,900
| New | +$239K | ﹤0.01% | 1044 |
|